Skip to main content
13 August 2026
27 April 2026

HanchorBio Partners with Bloomberg to Boost Pipeline & Strategy Execution

HanchorBio, Inc. , a global clinical-stage biotechnology company advancing next-generation immunotherapies for immuno-oncology and immune-related diseases, announced it has selected Bloomberg to support strategic decision-making across portfolio planning, pipeline development, competitive monitoring, business developm…

24 April 2026

Agilent Partners with OmixAI to Expand AI-Driven Proteomics in South Korea

Agilent Technologies Inc. announced a three-year strategic collaboration with OmixAI to advance next-generation precision medicine through AI-driven proteomics research, strengthening Agilent’s presence in fast-growing life sciences markets in Asia. The collaboration focuses on the joint development of automated sampl…

24 April 2026

Dawn Medical Technologies Enters Vietnam Market with Pinnacle Deal

Dawn Medical Technologies, CBC Group's MedTech commercialization platform, announced the acquisition of a controlling interest in Pinnacle Health Equipment Joint Stock Company, one of Vietnam's largest and most established full-service MedTech distributors. This strategic transaction marks Dawn's entry into the fast-g…

24 April 2026

OZMOSI Partners with Planview to Advance AI-Driven Pharma Portfolio Management

OZMOSI, a leading provider of structured pharmaceutical development intelligence, announced a strategic partnership with Planview, the leading AI-powered end-to-end platform for Strategic Portfolio Management (SPM) and Digital Product Delivery (DPD). This integration brings external clinical reality into internal R&a…

21 April 2026

UCB to acquire Neurona Therapeutics, advancing its innovative leadership in epilepsy

UCB (Euronext Brussels: UCB), a global biopharmaceutical company, announced that it has entered into a definitive agreement under which UCB would acquire Neurona Therapeutics, including lead asset NRTX-1001, adding to UCB's epilepsy portfolio. Neurona Therapeutics is a clinical-stage biotherapeutics company focused on…

21 April 2026

Lilly to acquire Kelonia Therapeutics to advance in vivo CAR-T cell therapies

Eli Lilly and Company and Kelonia Therapeutics, Inc., a clinical-stage biotechnology company pioneering in vivo gene delivery, today announced a definitive agreement for Lilly to acquire Kelonia. Kelonia has developed a proprietary in vivo gene placement system (iGPS® ) that uses specially engineered lentiviral-based…

21 April 2026

Medtronic plc completes CathWorks acquisition to boost coronary disease detection

Medtronic plc, a global leader in healthcare technology, announced it has completed its acquisition of CathWorks, a privately held medical device company, which aims to transform how coronary artery disease (CAD) is diagnosed and treated. The acquisition follows a 2022 strategic partnership with a co-promotion agreeme…

16 April 2026

Axtria Acquires Conexus to Build Unified AI-Driven CRM Platform

Axtria Inc., a global leader in AI-first data analytics solutions for the life sciences industry, announced the acquisition of Conexus Solutions, a premier life sciences technology and managed services partner specializing in CRM transformation across the Veeva and Salesforce ecosystems. With this acquisition, Axtria…

Page 10 of 36